Company intelligence / Profile preview

Genvara Biopharma, Inc.

Westminster, Colorado, USAgenvarabiopharma.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Completed two pharmacogenetic clinical trials that inform their clinical program. Ready for a Phase 3 pivotal trial with 30-50 patients. Using implanted devices to continuously monitor heart rhythm and calculate AF burden.

Therapeutic areas: Cardiovascular
Modalities: Small molecules (pharmacogenetically-targeted drugs)
Industry: Biotech

Drug pipeline

3 assets

ORKA-001

Phase 1

Indications: Psoriasis

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Genvara Biopharma, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genvara Biopharma, Inc..

Explore the full profile